Home » Newsletters » BioWorld Science

BioWorld Science

Feb. 12, 2008

View Archived Issues

Stanford University identifies two potential drug targets to treat malaria

Transcutaneous immunization effective in protecting against enterohemorrhagic E. coli infection

New antiinfective agents described in recent GSK patents

Activation of the unfolded protein response central in the pathogenesis of Charcot-Marie-Tooth 1B

Trophos receives grant to evaluate TRO-19622 in Parkinson's disease

Cogentus appoints Scientific Steering Committee for CGT-2168 phase III clinical program

University of Adelaide awarded AUD 2 million grant for five-year hepatitis C project

Toyama Chemical initiates phase II trial of T-5224 for rheumatoid arthritis

Takeda profiles Q3 developments

Risperidone long-acting injection delays relapse in bipolar disorder

Studies show aripiprazole efficacy in pediatric psychological disorders

Recent patents impart novel therapeutic agents for respiratory disorders

New antiinfective agents reported in recent patents

OctoPlus and Biolex commence phase IIa Locteron study in hepatitis C

MGCD-0103 receives orphan drug designation for acute myelogenous leukemia

Merck KGaA and Novo Nordisk disclose new diabetes compounds in recent patent literature

Pharmacopeia selects novel chemokine receptor antagonist for development

TopoTarget clarifies collaboration with Leo Pharma

Sosei commences AD-923 phase III studies in Europe

Promising interim results reported from phase III Zadaxin trial in hepatitis C

Symbollon Pharmaceuticals completes phase III trial of IoGen for fibrocystic breast disease

Solstice Neurosciences responds to FDA early communication regarding Myobloc for cervical dystonia

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 5, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 5, 2025.
Mesothelin is biomarker, potential target in arthritic bone damage
BioWorld Science
In a recent study published in Cell Reports Medicine, researchers from the Institute of Chinese Materia Medica of the China Academy of Chinese Medical Sciences...
Epigenetic technology could eliminate misfolded prion proteins
BioWorld Science
The number of deaths caused by prion diseases reaches about 30,000 annually. Only 5 months pass from the diagnosis of seemingly healthy patients to the fatal...
Gene therapies aim for the big goal of edits in vivo
BioWorld Science
The field of gene therapy is experiencing major advances driven by precise editing technologies, such as base and prime editing, and by the design of increasingly...